Provepharm Life Solutions, a French private pharmaceutical company that nfinds new applications for well-known molecules, announces that it has nbeen granted US FDA (Food and Drug Administration) authorization to nproduce its own active pharmaceutical ingredients (APIs) in order to nmanufacture drugs for the US market.
Axyntis Group signs 3 agreements offering opportunities to develop new activities and technologies through 3 million euros of investment
Provepharm`s Provayblue(Methylene Blue) approved in US for methemoglobinemia